Revised transparency rules for the EU Clinical Trials Information System

5 ottobre 2023 – The European Medicines Agency has adopted revised transparency rules for the publication of information on clinical trials submitted through the Clinical Trials Information System. The simplifications introduced will give access to clinical trial information to stakeholders including patients and healthcare professionals in a faster and more efficient way.

For more information, see here.